Premium
Dynamic clamping human and rabbit atrial calcium current: narrowing I CaL window abolishes early afterdepolarizations
Author(s) -
Kettlewell Sarah,
Saxena Priyanka,
Dempster John,
Colman Michael A.,
Myles Rachel C.,
Smith Godfrey L.,
Workman Antony J.
Publication year - 2019
Publication title -
the journal of physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.802
H-Index - 240
eISSN - 1469-7793
pISSN - 0022-3751
DOI - 10.1113/jp277827
Subject(s) - afterdepolarization , atrial fibrillation , medicine , nifedipine , cardiology , atrial action potential , electrophysiology , chemistry , ryanodine receptor , voltage clamp , calcium , repolarization
Key points Early‐afterdepolarizations (EADs) are abnormal action potential oscillations and a known cause of cardiac arrhythmias. Ventricular EADs involve reactivation of a Ca 2+ current ( I CaL ) in its ‘window region’ voltage range. However, electrical mechanisms of atrial EADs, a potential cause of atrial fibrillation, are poorly understood. Atrial cells were obtained from consenting patients undergoing heart surgery, as well as from rabbits. I CaL was blocked with nifedipine and then a hybrid patch clamp/mathematical‐modelling technique, ‘dynamic clamping’, was used to record action potentials at the same time as injecting an artificial, modifiable, I CaL ( I CaL,D‐C ). Progressively widening the I CaL,D‐C window region produced EADs of various types, dependent on window width. EAD production was strongest upon moving the activation ( vs . inactivation) side of the window. EADs were then induced by a different method: increasing I CaL,D‐C amplitude and/or K + channel‐blockade (4‐aminopyridine). Narrowing of the I CaL,D‐C window by ∼10 mV abolished these EADs. Atrial I CaL window narrowing is worthy of further testing as a potential anti‐atrial fibrillation drug mechanism.Abstract Atrial early‐afterdepolarizations (EADs) may contribute to atrial fibrillation (AF), perhaps involving reactivation of L‐type Ca 2+ current ( I CaL ) in its window region voltage range. The present study aimed (i) to validate the dynamic clamp technique for modifying the I CaL contribution to atrial action potential (AP) waveform; (ii) to investigate the effects of widening the window I CaL on EAD‐propensity; and (iii) to test whether EADs from increased I CaL and AP duration are supressed by narrowing the window I CaL . I CaL and APs were recorded from rabbit and human atrial myocytes by whole‐cell‐patch clamp. During AP recording, I CaL was inhibited (3 µ m nifedipine) and replaced by a dynamic clamp model current, I CaL,D‐C (tuned to native I CaL characteristics), computed in real‐time (every 50 µs) based on myocyte membrane potential. I CaL,D‐C ‐injection restored the nifedipine‐suppressed AP plateau. Widening the window I CaL,D‐C , symmetrically by stepwise simultaneous equal shifts of half‐voltages ( V 0.5 ) of I CaL,D‐C activation (negatively) and inactivation (positively), generated EADs (single, multiple or preceding repolarization failure) in a window width‐dependent manner, as well as AP alternans. A stronger EAD‐generating effect resulted from independently shifting activation V 0.5 (asymmetrical widening) than inactivation V 0.5 ; for example, a 15 mV activation shift produced EADs in nine of 17 (53%) human atrial myocytes vs . 0 of 18 from inactivation shift ( P < 0.05). In 11 rabbit atrial myocytes in which EADs were generated either by increasing the conductance of normal window width I CaL,D‐C or subsequent 4‐aminopyridine (2 m m ), window I CaL,D‐C narrowing (10 mV) abolished EADs of all types ( P < 0.05). The present study validated the dynamic clamp for I CaL , which is novel in atrial cardiomyocytes, and showed that EADs of various types are generated by widening (particularly asymmetrically) the window I CaL , as well as abolished by narrowing it. Window I CaL narrowing is a potential therapeutic mechanism worth pursuing in the search for improved anti‐AF drugs.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom